Treatment of Poorly Responsive Gamma-Hydroxybutyrate Withdrawal With Baclofen: A Case Report

被引：1
|
作者：
Lai, William [1 ]
Raposa, Jesse T. [2 ]
Parlapalli, Roop [3 ]
机构：
[1] Geisinger Hlth Syst, Internal Med, Wilkes Barre, PA 18765 USA
[2] Geisinger Med Ctr, Internal Med, Wilkes Barre, PA USA
[3] Geisinger Hlth Syst, Internal Med, Scranton, PA USA
来源：
CUREUS JOURNAL OF MEDICAL SCIENCE | 2022年 / 14卷 / 06期
关键词：
date rape drug; drugs of abuse; analgesics; substance abuse; gamma hydroxybutyrate; ghb; BUTYROLACTONE;
D O I：
10.7759/cureus.25728
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
Gamma-hydroxybutyrate (GHB) is a sedative often abused for its euphoric and relaxant effects. This case report looks to discuss a case of GHB intoxication in a 57-year-old gentleman, which resulted in an 11-day hospitalization due to withdrawal effects of his GHB dependence. His hospitalization and care primarily followed usual supportive care treatments; however, a novel use of baclofen to further expedite patient sedation reversal was done. This case report looks to explore the management of this patient's GHB toxicity and eventual resolution of symptoms using baclofen.
引用
收藏
页数：5
相关论文
共 50 条
  • [31] Lack of efficacy of benzodiazepines in treating gamma-hydroxybutyrate withdrawal - Reply
    Craig, K
    Gomez, HF
    Bania, TC
    JOURNAL OF EMERGENCY MEDICINE, 2001, 20 (04): : 419 - 420
  • [32] Gamma-hydroxybutyrate withdrawal syndrome: dangerous but not well-known
    van Noorden, Martijn S.
    van Dongen, Lieselotte C. A. M.
    Zitman, Frans G.
    Vergouwen, Ton A. C. M.
    GENERAL HOSPITAL PSYCHIATRY, 2009, 31 (04) : 394 - 396
  • [33] Clinical features and management of gamma-hydroxybutyrate (GHB) withdrawal: a review
    McDonough, M
    Kennedy, N
    Glasper, A
    Bearn, J
    DRUG AND ALCOHOL DEPENDENCE, 2004, 75 (01) : 3 - 9
  • [34] Development of a Protocol for the Management of Acute Gamma-hydroxybutyrate and Gamma-butyrolactone Withdrawal
    Wood, D. M.
    Dargan, P. I.
    CLINICAL TOXICOLOGY, 2010, 48 (03) : 306 - 307
  • [35] Gamma-hydroxybutyrate (GHB) withdrawal, first case management experience in the Philippine National Poison Management and Control Center: a case report
    Simene, Rutchell
    Dioquino, Carissa Paz
    CLINICAL TOXICOLOGY, 2020, 58 (04) : 330 - 330
  • [36] SODIUM GAMMA-HYDROXYBUTYRATE IN TREATMENT OF ESSENTIAL HYPERSOMNIA
    MONTPLAISIR, J
    BARBEZIEUX, M
    CANADIAN JOURNAL OF PSYCHIATRY-REVUE CANADIENNE DE PSYCHIATRIE, 1981, 26 (03): : 162 - 166
  • [37] BACLOFEN AND GAMMA-HYDROXYBUTYRATE DIFFERENTIALLY ALTERED BEHAVIOR, EEG ACTIVITY AND SLEEP IN RATS
    Hodor, A.
    Palchykova, S.
    Gao, B.
    Bassetti, C. L.
    NEUROSCIENCE, 2015, 284 : 18 - 28
  • [38] Physostigmine as a treatment for gamma-hydroxybutyrate toxicity: A review
    Traub, SJ
    Nelson, LS
    Hoffman, RS
    JOURNAL OF TOXICOLOGY-CLINICAL TOXICOLOGY, 2002, 40 (06): : 781 - 787
  • [39] The Neurobiological Mechanisms of Gamma-Hydroxybutyrate Dependence and Withdrawal and Their Clinical Relevance: A Review
    Kamal, Rama M.
    van Noorden, Martijn S.
    Franzek, Ernst
    Dijkstra, Boukje A. G.
    Loonen, Anton J. M.
    De Jong, Cornelius A. J.
    NEUROPSYCHOBIOLOGY, 2016, 73 (02) : 65 - 80
  • [40] Seven days of gamma-hydroxybutyrate (GHB) use produces severe withdrawal
    Perez, Eric
    Chu, Jason
    Bania, Theodore
    ANNALS OF EMERGENCY MEDICINE, 2006, 48 (02) : 219 - 220
12345